Sulindac
Who holds supplier records for Sulindac? 7 organisations hold a current record for Sulindac: an active US FDA Type II Drug Master File. A further 6 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3) and Italy (2); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Sulindac: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sulindac
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Sulindac. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AGNO PHARMAActive DMF 42166 · latest filing Jul 2025
- Aurore Life SciencesIndia Company GMP cert on recordActive DMF 36760 · latest filing Feb 2022
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 16180 · latest filing Oct 2002
- FIS FABBRICA ITALIANA SINTETICI SPAItaly Company GMP cert on recordActive DMF 6187 · latest filing Feb 1986
- JIANGSU ZW PHARMACEUTICALS CO LTDActive DMF 21102 · latest filing Nov 2007
- OLON SPAItaly Company GMP cert on recordActive DMF 12224 · latest filing Nov 1996
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 26004 · latest filing Apr 2012
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (6)
Organisations whose Type II DMFs for Sulindac are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- Italy · Inactive DMF 20742 · filed Jul 2007
- China · Inactive DMF 20104 · filed Dec 2006
- SIBEFAT SPAInactive DMF 7005, 8934 · filed Oct 1990
- SUMIKA FINE CHEMICALS CO LTDInactive DMF 8472 · filed Mar 1990
- Japan · Inactive DMF 7064 · filed Jun 1987
- DINAMITE DIPHARMA SPAInactive DMF 6439 · filed Jun 1986
Overview
Sulindac is a non-steroidal anti-inflammatory drug (NSAID) used to treat acute and chronic inflammatory conditions such as arthritis and bursitis. It functions by reducing inflammation and pain in the body.
Chemical identity
- IUPAC name
- 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
- Canonical SMILES
- CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
- InChIKey
- MLKXDPUZXIRXEP-MFOYZWKCSA-N
- Synonyms
- Clinoril API, arthrocine, artribid, clinoril, mk-231, nsc-757344
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
- Mechanism of action
- Cyclooxygenase Inhibitors
- Chemical structure
- Non-Steroidal
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Sulindac?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Sulindac: AGNO PHARMA, Aurore Life Sciences (India), Dr. Reddy's Laboratories Ltd. (India), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), JIANGSU ZW PHARMACEUTICALS CO LTD, OLON SPA (Italy) and Piramal Pharma Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Sulindac Drug Master Files are active?
AGNO PHARMA (DMF 42166), Aurore Life Sciences (DMF 36760), Dr. Reddy's Laboratories Ltd. (DMF 16180), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 6187), JIANGSU ZW PHARMACEUTICALS CO LTD (DMF 21102), OLON SPA (DMF 12224) and Piramal Pharma Limited (DMF 26004). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Sulindac records mean?
6 organisations have only inactive Type II DMFs for Sulindac. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Sulindac supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Sulindac?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.